NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1030220320

Registered date:03/09/2022

Development and exploration of an AI model to classify "schizophrenia with signs of relapse" and "schizophrenia with no signs of relapse" based on free conversations with medical staff

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedSchizophrenia
Date of first enrollment13/09/2022
Target sample size100
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeDevelopment and exploration of an following AI model based on free conversations with medical staff *to classify the signs of relapse for schizophrenic patient
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximum<= 65age old
GenderBoth
Include criteria1) Outpatient 2)Between 18 and 65 years of age at the time of consent and diagnosed with schizophrenia according to the DSM-5. 3)Who can obtain written consent from the person 4)Who speak Japanese as his/her mother tongue and able to have an interview (conversation with doctors and medical staff)
Exclude criteria1)Who has been judged by a doctor to have difficulty in having conversation due to deafness, dysarthria, aphasia, etc. 2)Who has been diagnosed of having a pyschiatric disorder such as depression 3)Who has been diagnosed of a dementia or judged to have cognitive dysfunction due to neurological diseases (epilepsy, stroke, etc.) 4)Who has been judged by a doctor not to be suitable for this trial by any reasons

Related Information

Contact

Public contact
Name Irisuna Hiroki
Address 2-12-23 Konan, Minato-ku, Tokyo Japan Tokyo Japan 108-0075
Telephone +81-80-4865-1308
E-mail hiroki_irisuna@fronteo.com
Affiliation FRONTEO Inc.
Scientific contact
Name Hiroyoshi Toyoshiba
Address 2-12-23 Konan, Minato-ku, Tokyo Japan Tokyo Japan 108-0075
Telephone +81-3-5463-6330
E-mail hiroyoshi_toyoshiba@fronteo.com
Affiliation FRONTEO Inc.